175 related articles for article (PubMed ID: 32748402)
61. Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis.
Kim JM; Miller JA; Kotecha R; Chao ST; Ahluwalia MS; Peereboom DM; Mohammadi AM; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Abraham J; Moore H; Budd GT; Suh JH
Neuro Oncol; 2019 May; 21(5):659-668. PubMed ID: 30726965
[TBL] [Abstract][Full Text] [Related]
62. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
Doherty MK; Korpanty GJ; Tomasini P; Alizadeh M; Jao K; Labbé C; Mascaux CM; Martin P; Kamel-Reid S; Tsao MS; Pintilie M; Liu G; Bradbury PA; Feld R; Leighl NB; Chung C; Shepherd FA
Radiother Oncol; 2017 May; 123(2):195-202. PubMed ID: 28363487
[TBL] [Abstract][Full Text] [Related]
63. Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial.
Churilla TM; Chowdhury IH; Handorf E; Collette L; Collette S; Dong Y; Alexander BM; Kocher M; Soffietti R; Claus EB; Weiss SE
JAMA Oncol; 2019 Feb; 5(2):243-247. PubMed ID: 30419088
[TBL] [Abstract][Full Text] [Related]
64. Patterns of Failure after Stereotactic Radiosurgery of the Resection Cavity Following Surgical Removal of Brain Metastases.
Strauss I; Corn BW; Krishna V; Shahar T; Matceyevsky D; Gez E; Shtraus N; Ram Z; Kanner AA
World Neurosurg; 2015 Dec; 84(6):1825-31. PubMed ID: 26283490
[TBL] [Abstract][Full Text] [Related]
65. Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases.
Bartsch R; Berghoff A; Pluschnig U; Bago-Horvath Z; Dubsky P; Rottenfusser A; DeVries C; Rudas M; Fitzal F; Dieckmann K; Mader RM; Gnant M; Zielinski CC; Steger GG
Br J Cancer; 2012 Jan; 106(1):25-31. PubMed ID: 22127284
[TBL] [Abstract][Full Text] [Related]
66. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract][Full Text] [Related]
67. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
68. Stereotactic radiosurgery for 318 brain metastases in a single Australian centre: the impact of histology and other factors.
Sia J; Paul E; Dally M; Ruben J
J Clin Neurosci; 2015 Feb; 22(2):303-7. PubMed ID: 25304434
[TBL] [Abstract][Full Text] [Related]
69. Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.
Shultz DB; Modlin LA; Jayachandran P; Von Eyben R; Gibbs IC; Choi CYH; Chang SD; Harsh GR; Li G; Adler JR; Hancock SL; Soltys SG
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):993-999. PubMed ID: 26194677
[TBL] [Abstract][Full Text] [Related]
70. Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis.
Nicosia L; Figlia V; Mazzola R; Napoli G; Giaj-Levra N; Ricchetti F; Rigo M; Lunardi G; Tomasini D; Bonù ML; Corradini S; Ruggieri R; Alongi F
Clin Exp Metastasis; 2020 Feb; 37(1):77-83. PubMed ID: 31691873
[TBL] [Abstract][Full Text] [Related]
71. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814
[TBL] [Abstract][Full Text] [Related]
72. Comparison of Surgical Resection and Stereotactic Radiosurgery in the Initial Treatment of Brain Metastasis.
Liu Z; He S; Li L
Stereotact Funct Neurosurg; 2020; 98(6):404-415. PubMed ID: 32898850
[TBL] [Abstract][Full Text] [Related]
73. Pyrotinib combining with radiotherapy on breast cancer with brain metastasis.
Ma X; Li Y; Zhao Z; Li L; Gao C; Liu D; Li B; Zhao B
Exp Biol Med (Maywood); 2023 Jan; 248(2):106-116. PubMed ID: 36533572
[TBL] [Abstract][Full Text] [Related]
74. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
75. Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis.
Depner JF; Berg T; Ejlertsen B; Andreasen LW; Møller S; Maraldo MV
Acta Oncol; 2023 Nov; 62(11):1502-1510. PubMed ID: 37750329
[TBL] [Abstract][Full Text] [Related]
76. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
[TBL] [Abstract][Full Text] [Related]
77. Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses.
Zhao B; Wang Y; Wang Y; Chen W; Zhou L; Liu PH; Kong Z; Dai C; Wang Y; Ma W
Aging (Albany NY); 2020 Jul; 12(14):14244-14270. PubMed ID: 32669477
[TBL] [Abstract][Full Text] [Related]
78. Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer.
Robin TP; Jones BL; Amini A; Koshy M; Gaspar LE; Liu AK; Nath SK; Kavanagh BD; Camidge DR; Rusthoven CG
Lung Cancer; 2018 Jun; 120():88-90. PubMed ID: 29748022
[TBL] [Abstract][Full Text] [Related]
79. Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02).
Phillips C; Pinkham MB; Moore A; Sia J; Jeffree RL; Khasraw M; Kam A; Bressel M; Haworth A
Breast; 2024 Apr; 74():103675. PubMed ID: 38340685
[TBL] [Abstract][Full Text] [Related]
80. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]